Abstract
. Introduction
twitch skeletal muscle, while SERCA1b is abundant in fetal and neonatal stages [1] . Four splice variants encode The sarcoplasmic reticulum (SR) is an intracellular for the SERCA2 isoforms, variant 1 translates in membrane system in cardiac cells, which plays a preSERCA2a, which is the primary isoform expressed in dominant role in cardiac excitation-contraction coupling cardiac and slow-twitch skeletal muscle tissue and variants 21 and cardiac contractility. A 1000-fold Ca -gradient is 2-4 encode for SERCA2b, which is the predominant maintained across the cardiac sarcoplasmic reticulum isoform in nonmuscle (variants 2 and 3) and neuronal cells 21 membrane by the SR Ca -ATPase (SERCA2a starts the crossbridge movement of the myofibrils resulting sory proteins may regulate the release mechanism at the in force development and contraction. Quick removal of SR level (Fig. 1) . 21 21 Ca into the SR or alternatively the extracellular lumen is The function and Ca activation of SERCA2a can be essential for cardiac relaxation. In cardiac tissue, this modulated by several indirect and direct factors. The most process is facilitated during diastole mainly by the SR predominant, indirect mechanism being the phosphoprotein 21 21 Ca -ATPase (70-80% of Ca removal in higher mamphospholamban, which associates with cardiac isoform malian species and human myocardium) and to a lesser SERCA2a [12, 13] . Phospholamban inhibits the apparent
affinity of SERCA2a for Ca in its dephosphorylated extent by the sarcolemmal Na , Ca -exchanger (20) (21) form. Upon phosphorylation of phospholamban through 30%) and slower Ca -transport systems [5] . In the SR, 21 21 b-adrenergic stimulation and enhanced cAMP-dependent Ca binds predominantly to the SR Ca binding protein 21 protein kinase A activity (PKA), the inhibition of phoscalsequestrin [6] and other Ca binding proteins, such as 21 pholamban on SERCA2a is relieved. This results in calreticulin and the histidine-rich-binding protein [7] . Ca 21 21 enhanced relaxation and increased SR Ca load. As a is stored close to the Ca release channel via the proteins direct modulation, SERCA2a is also under the control of triadin and junctin [8-10], which most likely facilitates a 21 21 Ca / calmodulin-dependent protein kinase II (CaMK II), faster Ca availability in the proximity of the ryanodine which has been shown to phosphorylate SERCA2a on receptor during early systole. In addition, a novel protein, 21 residue serine-38 and enhance the Ca transport capacity named junctate, has been described recently consisting of of SERCA2a [14, 15] . Other direct factors that modulate combined sequences of junctin and aspartyl-b-hydroxySERCA2a activity and expression are thyroid hormones lase, which may also influence SR release kinetics [11] .
[16], insulin [17] and nitrosylation [18] . Thus, SERCA2a is the main player in restoring diastolic 21 21 This review summarizes recent advances in understandCa levels and terminating Ca -dependent force activa- 21 ing the modulation of SR Ca sequestration by SERCA2a tion, while several other components, such as the phosfocusing especially on the: (a) regulators of SERCA2a phorylation state of the ryanodine receptor and its acces-21 21 21 Fig. 1. Schematic representation of myocardial Ca homeostasis. During systole, Ca enters the myocyte over L-type Ca channels (1) and induces a 21 21 Ca release of the ryanodine receptor from the sarcoplasmic reticulum (SR). During diastole Ca is subsequently transported into the SR via the SR 21 21 Ca -ATPase (SERCA2a), which is under the inhibitory control of phospholamban (PLB). The intracellular Ca concentration is modified by the
sarcolemmal Ca -ATPase (2), the Na / Ca -exchanger (3), the Na , K -ATPase (4), the sarcolemmal Na -channels (5), and the b-adrenoreceptor (6). 21 Diastolic SR Ca movement is modulated through alterations in SERCA2a function and PLB inhibition.
affinity and transport activation, (b) physiological role of phosphorylated protein was not determined. kinase II, and (c) serine 10 by Ca -activated phosinducing an infarct size larger than 30% resulted in 21 pholipid-dependent protein kinase (PKC) [22] [23] [24] [25] . Phossignificant depressed Ca / calmodulin-dependent phos- 21 phorylation by each protein kinase increases the apparent phorylation, reduced activity of the SR-associated Ca / 21 21 affinity of the SR Ca -ATPase for Ca and thereby, the calmodulin-dependent protein kinase and increased SR- 21 rate of Ca -sequestration into the SR [26] . The inhibitory associated phosphatases. This may in part explain deeffects of phospholamban are restored through dephospressed myocardial function in ischemic heart failure. 21 phorylation by an SR-associated phosphatase [26] . During However, co-regulatory processes involving Ca / calb-adrenergic stimulation both serine-16 and threonine-17 modulin as well as PKA-dependent pathways are feasible are phosphorylated, but the cAMP-dependent phosphorylaas well. tion site (serine-16) appears to be the most important
In addition to the direct phosphorylation of SERCA2a, 21 mediator to enhance cardiac contractility [27, 28] and has other studies [23, 24] have demonstrated a Ca / calbeen suggested to be the main regulator of the activity of modulin-dependent phosphorylation of the threonine-17 phospholamban. This was specifically demonstrated in site in phospholamban, which is accompanied by an 21 45 21 transgenic mouse models that overexpressed several muincreased affinity of SERCA for Ca as judged by Ca tant forms of phospholamban lacking these phosphorylauptake rates. Data from our laboratory indicate that this 21 21 tion sites [27, 29] . In human myocardium, the Ca -affinity Ca / calmodulin-dependent phosphorylation of threoninebut not the maximal velocity of SERCA2a was increased 17 in phospholamban can be modulated by the phosphatase via PKA-dependent phosphorylation of phospholamban calcineurin B [38] . Since continuous calcineurin activation [30] .
has been implicated in the development of hypertrophy A second mediator of SERCA2a activation has been [39] , this phosphatase-dependent activation may be one of 21 proposed to be the Ca / calmodulin-dependent protein the mechanisms by which the hypertrophied heart in- 21 kinase II. It was demonstrated that phosphorylation of creases diastolic Ca -availability and force of contraction. SERCA2a by CaMK II modulates the maximal activity (V ) of the enzyme without changing the apparent max affinity of the pump (EC ) [14, 15, 31] (Fig. 2) . Hawkins 3 . Lessons from animal models to elucidate the 50 et al. [32] showed that this phosphorylation was selective regulatory role of phospholamban and occurred in the cardiac and smooth muscle SR but not in the skeletal muscle SR. Using site-directed mutagenesis, Since SERCA2a is predominantly regulated through Toyofuku et al. [14] reported serine-38 as the CaMK II phospholamban, its functional role has been studied using phosphorylation site on SERCA2a. On the other hand, transgenic and gene-knockout mouse models. The murine Reddy et al. [33] did not observe SERCA2a phosphorylaphospholamban gene was ablated by homologous recombition in canine SR vesicles or purified SERCA2a preparanation in embryonic stem cells and phospholamban-detions. It must be noted that in this study [33] , there was a ficient mice were generated [13] . The phenotypical appearprotein of approximately the same molecular weight as that ance of these mice was similar to their wild-type controls of SERCA2a that was weakly phosphorylated in the at the morphological and histological levels [13] . However, 21 longitudinal SR and substantially phosphorylated in the the affinity of the SR Ca -ATPase, as judged by the EC 50 21 Fig. 2 . SR Ca -uptake function in nonfailing and failing human myocardium. Nonfailing myocardium is higher phosphorylated at the serine-16 site in 21 21 phospholamban than compared to failing myocardium, which goes in line with an increased Ca -sensitivity of SERCA2a for the SR Ca -transport upon knockout hearts. These findings were consistent with the phorylation of other key cardiac regulatory phosphopro- 21 previously defined functional modulation of the SR Cateins [44] . In addition, no compensatory mechanisms were ATPase upon phospholamban phosphorylation in native observed at the level of the myofilaments, as revealed by 21 SR membranes [22] . Physiological measurements in isothe myosin ATPase activity and the Ca -dependent force lated cardiac myocytes exhibited an enhanced myocyte development in skinned fiber experiments [45] . These data mechanics and parallel increase in amplitude and kinetics from animal studies indicate that phospholamban is a key 21 of rising and falling phases of Ca transients [40] . regulator of basal contractility and a major mediator of the Furthermore, phospholamban-deficient myocytes exhibited b-agonist responses in the mammalian heart [12]. 21 21 a higher SR Ca load [41] and the L-type Ca channel The phospholamban knockout studies suggested that the currents were significantly larger [42] . The hyperdynamic relative stoichiometric ratio of phospholamban to contractile function, observed in phospholamban-deficient SERCA2a may be a critical determinant of the regulation cardiomyocytes, was also apparent at the intact organ level of the cardiac contraction-relaxation cycle. In a second using work-performing heart preparations under identical approach, the effects of overexpressing phospholamban preload, afterload and heart rate [13] . In addition, isothrough transgenesis in murine hearts was investigated proterenol stimulation resulted in an attenuated contractile using the cardiac specific a-myosin heavy chain promoter response in isolated myocytes [40] , in whole hearts [13] or [46] . Phospholamban was overexpressed by two-fold comin intact animals [43] . Interestingly, the attenuation of pared to wild-type hearts. Similarly to the phospholambanb-agonist stimulation was not due to alterations in the deficient model, murine hearts from transgenic animals and b-adrenergic signaling pathway or the degree of phoswild-type controls were analysed at the molecular, bio-chemical and physiological levels. Transgenic mice overphospholamban to SERCA2a may be at least partially 21 expressing two-fold higher levels of phospholamban in the responsible for depressed kinetics of Ca transients and heart showed no morphological abnormalities and no contractile parameters in the mammalian heart [12]. alterations in heart:body weight compared to their wild- 21 type littermates. The affinity of the SR Ca -ATPase for 21 Ca was decreased in native SR preparations from 4 . Modified function of SERCA2a in human heart transgenic hearts and thus, it exhibited opposite properties failure than the phospholamban-deficient SR preparations [13] . The results may also hold true for changes at the level of
In human heart failure, several lines of evidence suggest 21 21 the SR Ca -release complex. Isolated cardiomyocytes that there are alterations in intracellular Ca -homeostasis, from transgenic animals exhibited decreases in shortening which may be related to an altered expression, function or 21 fraction and rates of shortening and relengthening, comregulation of Ca -handling proteins. Along these lines, 21 21 pared to wild-types controls. The amplitude of the Ca diminished peak and prolonged decay of Ca transients 21 signal was also decreased and the rate of decay of the Ca have been reported by several groups in cardiomyocytes transient in Fura-2 loaded transgenic cardiac myocytes was and papillary muscle strips isolated from hearts of patients 21 significantly prolonged, consistent with the decreased Ca with end-stage heart failure [50] [51] [52] . These alterations in 21 21 affinity of the SR Ca -ATPase. These findings were the rise and fall of the Ca -transient have important consistent with depressed contractile parameters at the implications for excitation-contraction coupling and the intact organ and whole animal levels. However, the development of increased diastolic tension in heart failure. 21 21 observed differences in contractile parameters, Ca kinetFurthermore, these alterations in Ca -handling diminish ics and depressed left ventricular function in vivo were frequency-potentiation, which is one of the potent intrinsic abolished upon isoproterenol stimulation [46] . These remechanisms inducing cardiac inotropy [53] [54] [55] [56] . This goes sults may be indicative for native SR, there is a fraction of in line with the finding that inhibition of SERCA activity 21 SR Ca -ATPase molecules, which is not subject to by CPA initiates, even in nonfailing human myocardium, a regulation by phospholamban.
negative force-frequency behaviour [30] . In a third approach, the effects of overexpression of a
The alterations in SR function and protein levels, as well nonphosphorylatable form of phospholamban, in which the as phosphorylation levels of phospholamban in human phosphorylation sites serine-16 and threonine-17 were congestive heart failure have been a matter of debate. Most mutated to alanine, was studied [29] . Several transgenic studies in human heart failure patients revealed that the lines were generated, which expressed 1.8-, 2.6-, 3.7-, and expression of phospholamban remains unchanged as com-4.7-fold mutated phospholamban over wild-type levels.
pared to nonfailing myocardium [54, 55, 57] , although one 21 Cardiac SR Ca -uptake experiments of these lines restudy reported a downregulation (18%) of phospholamban vealed that increasing levels of phospholamban were [58] . Based on the transgenic and gene-targeted mouse 21 accompanied by decrease in the apparent affinity for Ca . model studies, the phospholamban to SERCA2a ratio has Saturation of the phospholamban inhibitory effect on the been shown to be a major regulator of cardiac contractility 21 affinity of the SR Ca -ATPase was achieved at a ratio of [12, 29, 46] . Thus, any alterations in the expression levels of phospholamban to SERCA2a of 1 to 2.6, suggesting that phospholamban have to be examined in parallel with only 40% of the SERCA2a pumps are under the inhibitory possible alterations in the expression levels of SERCA2a. regulation of phospholamban in wild-type murine hearts Along these lines, it remains controversial whether [29] . However, it has to be emphasized that alterations in SERCA2a expression changes in human heart failure. the ratio of phospholamban to SERCA2a was determined Several studies reported a downregulation of SERCA2a in vitro on SDS gels without formally confirming alteraprotein [53, 58] , while others did not observe any signifitions in the ratio in vivo.
cant changes of SERCA2a expression in end-stage failing In addition to these three approaches on the ratio of human myocardium [54, 55, 57, 59] . A decrease in the phospholamban to SERCA2a, overexpression of mutant expression levels of SERCA2a may account for increased forms of phospholamban, such as the mutants L37A, I40A
PLB to SERCA2a ratios and thus, increased inhibition of [47], N27A [48] and V49G [49] as so-called the affinity of SERCA2a and prolonged relaxation. This superinhibitors of SERCA2a, have revealed that inhibition has been deduced from studies using crude membrane of SERCA by these mutants resulted in decreased SR preparations or highly purified vesicles [54] . In transgenic 21 Ca -uptake, diminished cardiac contractility and in vivo and gene-knockout mouse models, changes in SERCA2 systolic and diastolic function as well as cardiac failure expression have been mimicked to evaluate the potential in [49] . The inhibition of SERCA2a by these mutant was not vivo consequences. The SERCA2a knockout model [60] dependent on a primarily pentameric or monomeric from exhibited in the heterozygous knockout, a 45% reduction of phospholamban.
in SERCA2a expression levels, which was accompanied 21 Based on the studies in genetically engineered phosby decrease in SR Ca -uptake function and cardiac pholamban mouse models, increase in the apparent ratio of contractility, as judged by the 2 dP/dt values and mean arterial pressure. The homozygous SERCA2a knockout is mainly because of continued improvements in vector most likely lethal, since it was not observed in heterotechnology, cardiac gene delivery and better understanding zygous cross mating [60] . In addition, impaired contractiliof the molecular basis of heart failure. Upcoming studies 21 ty and hypertrophy was observed in a splice-variant model, will show whether improving Ca handling function may in which SERCA2a was replaced by SERCA 2b [61] . On prove to be a beneficial target for treating the progression the other hand, increases in the expression of SERCA2a of cardiac failure not only in experimentally induced heart and 2b in transgenic mice have been shown to increase SR failure, but also in the clinical setting. 21 Ca -function and enhance cardiac contractility [62, 63] . In a rat heart failure model using adenoviral gene transfer to overexpress SERCA2a, impaired cardiac function was A cknowledgements restored to normal levels and myocardial energetics was not affected by increased SERCA2a expression [64] . These
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